Methyl ester derivatives of cinnamic acid as key intermediates for HDAC inhibitor synthesis
Specialized chemical intermediates (methyl ester derivatives of cinnamic acid) designed as precursors for novel alkoxyamide and alkoxyurea analogs of the HDAC inhibitor panobinostat. Supports research into antiproliferative agents, HDAC isoform profiling, and cisplatin resistance.
Overview
This offering centers on methyl ester derivatives of cinnamic acid, which serve as key synthetic intermediates for the development of novel HDAC (histone deacetylase) inhibitors. The intermediates are specifically designed as precursors for alkoxyamide and alkoxyurea analogs of the clinically validated HDAC inhibitor panobinostat. The underlying research aims to advance new therapeutic candidates with improved antiproliferative activity, refined HDAC isoform selectivity, and potential efficacy against cisplatin-resistant cancer cell lines.
Technical specifications
- Intermediate type: Methyl ester derivatives of cinnamic acid
- Target class: Alkoxyamide and alkoxyurea analogs of panobinostat
- Application focus: HDAC inhibitor synthesis and medicinal chemistry optimization
- Research scope: Antiproliferative activity evaluation, HDAC isoform profiling, and investigation of cisplatin resistance mechanisms
- Expertise: Synthetic organic chemistry with specialization in HDAC inhibitor design and analog development
Technology readiness level
The intermediates have been synthesized as part of an active medicinal chemistry research program focused on developing and evaluating novel panobinostat analogs. The work supports ongoing investigation into biological activity and selectivity profiles, positioning the intermediates at an early-stage research and development phase suitable for collaborative drug discovery partnerships.
About Heinrich Heine Universität Düsseldorf
Heinrich Heine Universität Düsseldorf is a comprehensive public research university anchored by a major medical faculty and a modern science campus. An integrated university hospital and shared core facilities enable clinical translation and access to specialized instrumentation for joint studies. Companies collaborate through on‑campus spaces, contract research, and tailored partnership models, with quick reach to suppliers and manufacturing across North Rhine‑Westphalia’s Rhine‑Ruhr corridor. Research is supported by competitive funding from the German Research Foundation and federal and state ministries, alongside European Union programs. A dedicated technology transfer office manages IP, licensing, and startup support to accelerate industry uptake.
delivered to your inbox.